position: EnglishChannel > Sci-Tech News > Article

Can plant-based vaccines help in the fight against COVID-19?

Source: International Communication Center for Science & Technology| 2020-05-18 19:28:49| Author: Zhao Hanbin Lu Zijian & China.org.

A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 11, 2020. [Photo/Xinhua]

As potential COVID-19 vaccines enter human clinical trials, people have started to consider another problem: Once a vaccine is available, how can it be produced in sufficient quantities to meet the needs of billions of people around the world? 

Plant-based vaccines use genetic engineering technologies to introduce the antigen genes of pathogenic microorganisms into the plant genome, allowing the antigen protein to grow steadily within the edible part of the plant. This then creates an edible vaccine that can be taken orally. 

Since the birth of the world's first genetically engineered plant in 1983, more than 100 pathogenic microorganism antigen genes have been integrated into the plant genome, and some genetic products have been confirmed as immunogenic via animal experiments. Reports show that several dozen vaccines have now been produced in plants using genetic engineering technology. These plant-derived vaccines can be produced to target such contagions as the hepatitis B virus, foot-and-mouth disease virus, rabies virus glycoprotein, tubercle bacillus and rotavirus. 

Studies have shown that genes encoding hepatitis B virus surface antigens can be successfully expressed in tobacco, tomato, potato, lupin and lettuce plants. In recent years, Chinese researchers have introduced surface antigen genes for the hepatitis B virus into cherries, apples, potatoes and tomatoes to create genetically modified plants and express active hepatitis B virus surface antigen proteins. At present, the highest expression of the surface antigen is in potatoes. 

Luo Wen and Liu Ruiqi with the School of Biotechnology at Xi'an University introduced the main steps in developing plant vaccines. These involve cloning the target gene and connecting it to a vector that can be expressed in plants to construct an efficient plant expression vector; introducing foreign genes into plants, allowing the plants to carry specific antigen-encoding genes, achieving genetic transformation of plant cells, and culturing tissue of recipient cells and plant regeneration via genetic engineering technologies; detecting the expression of antigen protein genes in plants; and isolating, purifying and conducting purity identification of the target products; as well as testing the antigenicity and immunogenicity of plant expression products. 

Guan Zhengjun at the Key Laboratory of Resource Biology and Biotechnology in Western China, a lab jointly-built by China's Ministry of Education and Northwest University, told Science and Technology Daily that an edible vaccine based on genetically modified plants is one of the most promising directions for producing a new vaccine. Compared with traditional vaccines, plant-based vaccines are not only cheap, but the antigenic proteins expressed in them do not require extraction, purification and refrigeration, which greatly reduces the cost of production and transportation, and they are also relatively safe and effective. 

Plant-based genetic engineering technologies have gradually matured and brought broad prospects for the development of oral vaccines. For example, tomatoes — which are delicious, inexpensive and nutritious — are one of the most commonly used receptor materials for genetic engineering technologies. The ability for them to be eaten raw also prevents possible damage to foreign proteins during the heating process. 

However, at the same time, the safety and reliability of vaccines are always foremost concerns. In recent years, people have seen that there are still some uncertainties surrounding plant-derived oral vaccines, such as low expression of foreign proteins, possible digestion and degradation when taken orally, and safety issues. As such, anticipation for the technology has somewhat declined. How to solve these problems has become a major test for the development of future plant-based oral vaccines. 

(You can also read this article at: http://138cpwdr.165sun.com/china/2020-05/15/content_76049250.htm)


Editor:余昊原

Top News

Chinese and Malaysian Media and Think Tanks Discuss Sci-Tech Cooperation to Empower the Future

The Technology Empowering the Future:China-Malaysia Think Tank and Media Cooperation Forum was held on January 15, 2021.Representatives from Chinese and Malaysian media think tanks and sci-tech enterprises conducted in-depth discussions on "Empowering the Future through Technology -- New Prospects for Digital Cooperation between Think Media in the 5G Era".

China was in the front line of the epidemic and made key contributions to the scientific community

China held a ceremony in Beijing?for?honoring people fighting COVID-19 with national medals?on September?8.?To?know?more?about?the?international?reactions,?Science?and?Technology?Daily?Reporter?Zhang?Jiaxing?interviewed?Dr. Lawrence Banks?and Dr. Alessandro Marcello?from?International?Centre?Engineering?and?Biotechnology.

Copyright ? Science and Technology Daily, All Rights Reserved

mailto: yuhy@stdaily.com

网站地图 070彩票网安全不登入 金誉彩票网平台登入 盛兴彩票网是正规的吗登入
太阳城电子娱乐游戏 进入申博138 菲律宾申博官方直营网 澳门网上赌场排名
乐玩棋牌游戏 威尼斯人vns开户 XTD旗舰馆娱乐ag8820 丹阳棋牌游戏中心
金誉彩票网登录不上登入 138彩票游戏登入 盛兴彩票网v3登入 乐趣彩票登录登入
138彩票官方网登入 盛兴彩票是合法的吗登入 7070彩票游戏登入 138彩票app下载登入
55sbib.com S618K.COM XSB173.COM vi138.com 618cw.com
XSB345.COM 7TGP.COM 122TGP.COM 198XTD.COM dx138.com
3445111.COM 988TGP.COM 16jbs.com 888sbsg.com 88sbsun.com
919psb.com XSB798.COM 487SUN.COM 22sbsg.com 777sbsb.com